Isodent - Vastaanoton suuvesi

The first Finnish mouthwash designed to defend against Coronavirus

The Benefits

Coronavirus

The Coronavirus spreads primarily through droplet infection from coughing or sneezing.

Decrease The Viral Load

Isodent’s ‘Vastaanoton suuvesi’ consists of hydrogen peroxide (1,5%) that inactivates viruses in saliva and the oral cavity.

Protect and Defend

When the user rinses for 60 seconds with the product, the viral load of the aerosol produced during the treatment will decrease. The risk for exposure is reduced. Protect yourself and your staff.

Developed in Finland

Isodent Oy has developed the product in collaboration with the dentists of HammasOskari Oy. This is the first product developed for this indication.

The Basis of the Product

The latest scientific evidence suggests that use is recommended prior to dental treatment (1,2). The American Dental Association recommends the use of hydrogen peroxide based mouthwash to increase the level of hygiene (3).

Safety

“We add another layer of safety by decreasing the viral load. Using a hydrogen peroxide based product decreases the exposure of airborne viruses for the staff. During these times one cannot underestimate the steps that need to be taken to ensure the best level of safety. “

DMD Leo Nylander, Chief Medical Officer, Chairman of the Board, HammasOskari Oy

Saa ensimmäisenä tieto tulevista myyntipaikoista jättämällä sähköpostiosoitteesi alle

Available for purchase online and in select distributors

Product information

Sales inquiries and orders

1)Peng, X., Xu, X., Li, Y. et al. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci 12, 9 (2020). https://doi.org/10.1038/s41368-020-0075-9

2)Coronavirus Frequently Asked Questions, ADA center for professional success (American Dental Association) Mar 27, (2020) https://success.ada.org/en/practice-management/patients/coronavirus-frequently-asked-questions

3)Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
Kampf, G. et al. Journal of Hospital Infection, Volume 104, Issue 3, 246 ‚Äď 251

4) World Health Organization. (‚Äé2020)‚Äé. Laboratory biosafety guidance related to coronavirus disease 2019 (‚ÄéCOVID-19)‚Äé: interim guidance, 12 February 2020. World Health Organization. https://apps.who.int/iris/handle/10665/331138. License: CC BY-NC-SA 3.0 IGO

Help other people by raising awareness about this product